Article
Patients with an ApoE epsilon4 allele require lower doses of coumarin anticoagulants.
Pharmacogenetics and genomics - 1 Feb 2005
Visser Loes E, Trienekens Paul H, De Smet Peter A G M, Vulto Arnold G, Hofman Albert, van Duijn Cornelia M, Stricker Bruno H Ch
Abstract excerpt
OBJECTIVE: Vitamin K is an essential cofactor for the synthesis of several blood coagulation factors. It has been suggested that the apolipoprotein E (ApoE) genotype has profound effects on vitamin K status. Therefore, we investigated whether this common genetic polymorphism influenced dose requirements and effects of coumarin anticoagulants. METHODS: We did a cohort study in 1637 patients from an outpatient...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
